ReadYourDNA

Pitrakinra

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Pitrakinra

What it is

Pitrakinra was an experimental medicine for asthma, a modified form of interleukin-4 that blocks the IL-4 receptor alpha chain and so both IL-4 and IL-13 signalling, key drivers of allergic airway inflammation. It was tested as an inhaled treatment in clinical trials but was not approved; dupilumab, an antibody acting on the same receptor, later reached the market.

How genes come into it

The gene studies on pitrakinra came from one clinical trial, which found that people with certain variants in IL4R, the gene for its target receptor, had fewer asthma flare-ups on it. This was an early example of matching an asthma treatment to a patient's genes, but the medicine was not developed further. There is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Pitrakinra. Upload your DNA file to see which of these rows apply to you.

Rated evidence (6 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

IL4R rs3024530: Level 3. Efficacy: Asthma. 1.

IL4R rs1110470: Level 3. Efficacy: Asthma. 1.

IL4R rs2239347: Level 3. Efficacy: Asthma. 1.

IL4R rs1805010: Level 3. Efficacy: Asthma. 1.

Response (6 findings)

Studies of how well it worked in people carrying a variant.

IL4R rs1029489: Genotype GG is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AA + AG.

IL4R rs1110470: Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.

IL4R rs1805010: Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AG + GG.

IL4R rs2239347: Genotype AA is associated with increased response to pitrakinra in people with Asthma as compared to genotypes AC + CC.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Aciphex (PPIs)

Advair (Corticosteroid + LABA)

AeroBid (Corticosteroids)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com